Cargando…
Brief Report: Intraarticular Sprifermin Not Only Increases Cartilage Thickness, but Also Reduces Cartilage Loss: Location‐Independent Post Hoc Analysis Using Magnetic Resonance Imaging
OBJECTIVE: To determine whether an anabolic drug (sprifermin) is capable of reducing cartilage loss wherever it occurs in a given knee, using a subject‐specific, location‐independent analysis of cartilage change in patients with knee osteoarthritis (OA). METHODS: Study participants (n = 168; ages ≥4...
Autores principales: | Eckstein, Felix, Wirth, Wolfgang, Guermazi, Ali, Maschek, Susanne, Aydemir, Aida |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5061102/ https://www.ncbi.nlm.nih.gov/pubmed/26138203 http://dx.doi.org/10.1002/art.39265 |
Ejemplares similares
-
Intra-articular sprifermin reduces cartilage loss in addition to increasing cartilage gain independent of location in the femorotibial joint: post-hoc analysis of a randomised, placebo-controlled phase II clinical trial
por: Eckstein, Felix, et al.
Publicado: (2020) -
Structural effects of sprifermin in knee osteoarthritis: a post-hoc analysis on cartilage and non-cartilaginous tissue alterations in a randomized controlled trial
por: Roemer, Frank W., et al.
Publicado: (2016) -
Long-term structural and symptomatic effects of intra-articular sprifermin in patients with knee osteoarthritis: 5-year results from the FORWARD study
por: Eckstein, Felix, et al.
Publicado: (2021) -
Detection of Differences in Longitudinal Cartilage Thickness Loss Using a Deep‐Learning Automated Segmentation Algorithm: Data From the Foundation for the National Institutes of Health Biomarkers Study of the Osteoarthritis Initiative
por: Eckstein, Felix, et al.
Publicado: (2022) -
Thickness of the bone-cartilage unit in relation to osteoarthritis severity in the human hip joint
por: Hartlev, Louise Brøndt, et al.
Publicado: (2018)